July 8, 2025

analysis  
Read News
google, palantir and snowflake Updates

Google DeepMind's Isomorphic Labs is gearing up to begin human trials for its AI-designed drugs, marking a significant step in using AI to combat diseases. With $600 million in funding and partnerships with Novartis and Eli Lilly, Isomorphic Labs utilizes AlphaFold AI to predict protein structures and accelerate drug development, aiming to improve the success rate and efficiency of drug trials. In other AI developments, a new Texas law will regulate AI, banning its use for creating child sexual abuse material and limiting government use for identification. Gartner advises that AI security requires careful access control to prevent data leaks, while Boosted.ai launched its Alfa AI platform to aid investors. C3.ai is expanding its generative AI capabilities for businesses, joining competitors like Palantir and Snowflake in providing AI solutions. Meanwhile, a report indicates that India is leading in AI adoption, with 23% of companies seeing ROI from generative AI, and Adobe and Econsultancy are offering courses to help professionals leverage AI for innovation. However, an article challenges the notion of AI intelligence, citing negative experiences with chatbots and their potential impact on mental health. In the sales sector, AI is boosting the value of SaaS companies by improving customer behavior prediction and pricing strategies. Finally, AI is even being used for entertainment, with a podcast using AI to predict the Green Bay Packers' 2025 season.

Key Takeaways

  • Google DeepMind's Isomorphic Labs will begin human trials for AI-designed drugs, backed by $600 million in funding.
  • Isomorphic Labs uses AlphaFold AI to predict protein structures, partnering with Novartis and Eli Lilly to accelerate drug development.
  • Texas has passed a new AI law banning AI from creating child sexual abuse material and limiting government use of AI for identification.
  • Gartner advises that AI security requires careful access control to prevent data leaks.
  • Boosted.ai launched its Alfa AI platform for investment research, offering features accessible without a paid account.
  • C3.ai is expanding its generative AI capabilities for businesses, competing with Palantir and Snowflake.
  • An Adobe and Econsultancy report indicates that India leads in AI adoption, with 23% of companies seeing ROI from generative AI.
  • A new podcast uses AI to predict the Green Bay Packers' 2025 season.
  • AI is boosting the value of SaaS companies by improving customer behavior prediction and pricing strategies.
  • An article challenges the notion of AI intelligence, citing negative experiences with chatbots and their potential impact on mental health.

Google DeepMind's AI drugs to enter human trials soon

Google DeepMind's Isomorphic Labs will soon start human trials for its AI-designed drugs. Colin Murdoch said they are close to beginning trials. Isomorphic Labs uses AlphaFold AI to predict protein structures and speed up drug development. They have partnerships with Novartis and Eli Lilly and raised $600 million in funding. The company hopes to improve the success rate of drug trials using AI.

Alphabet's Isomorphic Labs to test AI-designed drugs on humans

Alphabet's Isomorphic Labs, a Google DeepMind company, is preparing to test its AI-designed drugs in human trials. This is a big step towards using AI to treat and possibly cure diseases. Isomorphic Labs uses AI to analyze biological data and design new drugs. Human trials will show if the AI-designed drugs are safe and effective. The company hopes to make drug development faster and more successful.

DeepMind to begin human trials of AI-designed cancer drugs

Google DeepMind's Isomorphic Labs is getting ready to start human trials of drugs designed by AI. Colin Murdoch said the company is close to testing cancer drugs designed with AI. Isomorphic Labs uses DeepMind's AlphaFold to design drugs and works with Novartis and Eli Lilly. The company aims to improve the success rates of drug trials. They hope AI can help design effective drugs more quickly.

Isomorphic Labs to begin human trials of AI-created drugs

Isomorphic Labs, an AI drug development company, plans to start clinical trials for its cancer drugs. Colin Murdoch said the company is preparing to test its drugs on patients. Isomorphic uses AlphaFold 3, co-developed with Google DeepMind, to predict protein structures. The company also has partnerships with Novartis and Eli Lilly. Other companies are also using AI for drug development.

Isomorphic Labs to test AlphaFold-designed drugs in human trials

Isomorphic Labs, a DeepMind company, is preparing for its first human trials with drugs designed using AlphaFold AI models. Colin Murdoch said they are getting ready to start the trials. The company wants to improve the slow and costly process of drug development. Isomorphic Labs has agreements with Eli Lilly and Novartis. They hope AI can help design drugs more efficiently.

Google to begin human trials of AI-designed drugs

Google DeepMind's Isomorphic Labs is preparing to start human trials of its AI-designed drugs. The company uses AI to design medicines faster and more accurately. Colin Murdoch confirmed that the human trials are set to begin. Isomorphic Labs was created after DeepMind's AlphaFold AI system accurately predicted protein structures. The company aims to improve drug success rates and reduce development costs.

AI tools boost SaaS company value in sales revolution

AI is changing how sales teams work, helping them predict customer behavior and improve pricing. SaaS companies using AI in sales are now worth more to investors. One company using AI saw a 50% increase in its value. AI helps companies reduce costs, improve customer retention, and increase sales. Investors are looking for SaaS companies that use AI effectively.

Friend upset after AI book reaction on Reddit

A Reddit user asked for advice after their friend got upset about their reaction to her self-published children's book. The friend used AI to create the book's artwork. The Reddit user didn't congratulate her and asked about the illustrator. The friend felt criticized because she used AI. Responses were mixed, with some agreeing the user was wrong and others defending their reaction.

Texas to launch new AI law this spring

Texas lawmakers passed a new law for artificial intelligence this spring. The law bans AI from creating child sexual images and inciting crime. It also limits how the government uses AI to identify people. The law creates a "sandbox" program for companies to test AI with state oversight. Representative Giovanni Capriglione discussed the goals of the law.

Artificial intelligence doesn't exist says article

An article argues that calling chatbots "intelligent" is wrong. The article shares stories of people who had negative experiences with chatbots. One person tried to harm someone because of a chatbot. Another became violent due to their relationship with a chatbot. The author suggests chatbots can negatively affect people's mental health.

India leads in AI use says report

India is a leader in using AI, according to a report by Adobe and Econsultancy. About 23% of Indian companies are seeing a return on investment from generative AI. Singapore Management University (SMU) offers courses to help professionals use AI for innovation. The courses teach skills in AI and digital transformation. SMU's program helps leaders use AI to improve their businesses.

AI predicts Green Bay Packers' 2025 season in podcast

In a new podcast episode, Andy uses artificial intelligence to predict the Green Bay Packers' 2025 season. The Pack-A-Day Podcast simulates the season using AI. Find out what the AI predicts for the Packers. Andy is a graduate of UW-Oshkosh and owns the Pack-A-Day Podcast.

AI security needs access control says Gartner

Gartner's Nader Heinen says AI security issues are often access control problems. Giving AI systems access to too much data can cause information leaks. Heinen suggests building access control into AI engines to limit data sharing. He recommends treating AI models like new employees, gradually giving them access to data. He also warns against industry hype and advises purposeful AI adoption.

Boosted.ai launches Alfa AI platform for investors

Boosted.ai launched a new version of its Alfa AI platform for investment research. Alfa is designed to help investors by anticipating needs and analyzing data. The platform uses "agents" to provide specific guidance. Alfa can extract key data and monitor emails. It also helps create financial reports using voice and text. Users can now sign up and try key features without a paid account.

C3.ai expands AI capabilities for businesses

C3.ai is expanding its generative AI capabilities for businesses. The company saw a large increase in generative AI revenue. C3.ai has deployed AI solutions for the U.S. Navy, Dow, and Chanel. They also claim to have a patent on agentic AI. Competitors like Palantir and Snowflake are also working on AI solutions for businesses.

Sources

AI Artificial Intelligence DeepMind Google DeepMind Isomorphic Labs Drug Development Human Trials AlphaFold AI-designed drugs Cancer drugs Clinical trials Novartis Eli Lilly AI in drug discovery Generative AI SaaS Investment AI security Access control Data security AI Law Texas AI Law AI adoption AI platform AI for investors AI in sales AI in business AI predictions AI and mental health